Wiseguyreports.Com Adds “Global Neglected Tropical Disease Treatments Market to Grow at Notable Pace by 2024” To Its Research Database
Neglected tropical diseases (NTDs) are different types of tropical infections that are prevalent in the developing regions of America, Africa and Asia. These infections are caused due to pathogens such as bacteria, viruses, protozoa, and helminthes. Therefore, many organizations across the world are taking initiatives to increase NTD awareness and improve access to medicines. According to report analysts, the global neglected tropical disease treatments market will record a CAGR of 14.1% between 2016 and 2021. From US$ 1.4 billion in 2016, the NTD treatment market should reach US$ 2.6 billion by 2021.
Reports suggest that neglected tropical diseases are common in 149 countries and have affected more than one billion people. Poor living conditions, inadequate sanitation and close contact with infection-causing vectors are the main reasons. Public health organizations are taking appropriate measures to detect, prevent and control NTDs in the affected regions around the world. Organizations, such as WHO, GHIT and UNDP are also taking initiatives to make neglected tropical disease medicines easily available in the developing nations. These factors will further drive the global neglected tropical disease treatments market.
Considering the growing incidence of neglected tropical diseases such as lymphatic filariasis, dengue, leishmaniasis and trachoma in many regions, researchers are focusing on developing medicines to deal with these conditions. Many missions are being initiated in developing economies like India to reduce dengue-related mortality. They include easy access to clean water and improved sanitation practices. This report provides in-depth insights into the global neglected tropical disease treatment market to help manufacturers and key players plan their future strategies accordingly.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2820066-global-markets-for-neglected-tropical-disease-treatments
The global neglected tropical disease treatments market is segmented into drug types, disease types, end-users, and distribution channels.
Based on drug types, the market is divided into antiparasitic drugs, antibacterial drugs and antiviral drugs.
Based on disease types, the market is divided into dengue, chagas disease, chikungunya, lymphatic filariasis, rabies and others.
Based on end-user, the market is divided into public and private.
Based on distribution channels, the market is segmented into retail pharmacies, hospital pharmacies and others.
The main regions considered for analyzing the global neglected tropical disease treatments market are North America (The United States and Canada), Europe (France, Italy, Germany, UK, Russia, Spain and rest of the region), Asia-Pacific (India, South Korea, Japan, China, Australia, Singapore, Indonesia and rest of the region), Latin America (Brazil, Mexico, Chile, Peru and rest of the region), and the Middle East and Africa (UAE, Egypt, Turkey, Saudi Arabia and South Africa).
Asia-Pacific dominates the global NTD treatments market owing to increasing cases of neglected tropical diseases in populated countries such as China, India, Indonesia and Bangladesh. Latin America and MEA regions are likely to witness good market growth over the forecast period. The rest of the world (ROW) also holds a large market share because of the high prevalence of NTDs related to poor sanitation facilities.
In January 2019, the United Nations Development Program (UNDP) along with other organizations took the initiative to improve access to diagnostics, medicines, and vaccines for neglected tropical diseases in underdeveloped and developing countries.
Profiles of major players in the industry
(DNDI) Drugs For Neglected Diseases Initiative
(MMV) Medicines For Malaria Venture
Anacor Pharmaceuticals (NOW PFIZER)
Sabin Vaccine Institute
The Path Malaria Vaccine Initiative
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)